C. B. Yoo and P. A. Jones, Epigenetic therapy of cancer: past, present and future, Nature Reviews Drug Discovery, vol.316, issue.1, p.37, 2006.
DOI : 10.1038/nrd1930

A. C. Ferguson-smith and J. M. Greally, Epigenetics: Perceptive enzymes, Nature, vol.12, issue.7159, p.148, 2007.
DOI : 10.1038/449148a

F. J. Dekker and H. Haisma, Histone acetyl transferases as emerging drug targets, Drug Discovery Today, vol.14, issue.19-20, p.942, 2009.
DOI : 10.1016/j.drudis.2009.06.008

J. E. Bolden, M. J. Peart, and R. W. Johnstone, Anticancer activities of histone deacetylase inhibitors, Nature Reviews Drug Discovery, vol.106, issue.9, p.769, 2006.
DOI : 10.1038/nrd2133

M. Mottamal, S. Zheng, T. L. Huang, and G. Wang, Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents, Molecules, vol.20, issue.3, p.3898, 2015.
DOI : 10.3390/molecules20033898

C. Grant, F. Rahman, R. Piekarz, C. Peer, R. Frye et al., Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors, Expert Review of Anticancer Therapy, vol.10, issue.7, p.997, 2010.
DOI : 10.1586/era.10.88

M. Duvic and . Vu, Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma, Expert Opinion on Investigational Drugs, vol.19, issue.7, p.1111, 2007.
DOI : 10.1038/nrd2133

M. P. Fenichel, Cancer Inst, 2015.

J. C. Bressi, A. J. Jennings, R. Skene, Y. Wu, R. Melkus et al., Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.10, p.3142, 2010.
DOI : 10.1016/j.bmcl.2010.03.091

B. E. Lauffer, R. Mintzer, R. Fong, S. Mukund, C. Tam et al., Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability, Journal of Biological Chemistry, vol.288, issue.37, p.26926, 2013.
DOI : 10.1074/jbc.M113.490706

L. Loudni, J. Roche, V. Potiron, J. Clarhaut, C. Bachmann et al., Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.17, issue.17, p.4819, 2007.
DOI : 10.1016/j.bmcl.2007.06.067

C. Pérez-balado, A. Nebbioso, P. Rodríguez-graña, A. Minichiello, M. Miceli et al., Bispyridinium Dienes:?? Histone Deacetylase Inhibitors with Selective Activities, Journal of Medicinal Chemistry, vol.50, issue.10, p.2497, 2007.
DOI : 10.1021/jm070028m

A. K. Chatterjee, T. Choi, D. P. Sanders, and R. H. Grubbs, A General Model for Selectivity in Olefin Cross Metathesis, Journal of the American Chemical Society, vol.125, issue.37, p.11360, 2003.
DOI : 10.1021/ja0214882

M. A. Staszak and C. W. Doecke, The use of N,O-bis(tert-butoxycarbonyl)-hydroxylamine in the synthesis of N-hydroxylamines and hydroxamic acids, Tetrahedron Letters, vol.35, issue.33, p.6021, 1994.
DOI : 10.1016/0040-4039(94)88064-6

B. Kim, H. Park, L. A. Salvador, P. E. Serrano, J. C. Kwan et al., Evaluation of class I HDAC isoform selectivity of largazole analogues, Bioorganic & Medicinal Chemistry Letters, vol.24, issue.16, p.3728, 2014.
DOI : 10.1016/j.bmcl.2014.07.006

Y. Itoh, T. Suzuki, A. Kouketsu, N. Suzuki, S. Maeda et al., Design, Synthesis, Structure???Selectivity Relationship, and Effect on Human Cancer Cells of a Novel Series of Histone Deacetylase 6-Selective Inhibitors, Journal of Medicinal Chemistry, vol.50, issue.22, p.5425, 2007.
DOI : 10.1021/jm7009217

K. Haack, Y. Ahn, and G. Georg, A convenient method to remove ruthenium byproducts from olefin metathesis reactions using polymer-bound triphenylphosphine oxide (TPPO), Molecular Diversity, vol.44, issue.4, p.301, 2005.
DOI : 10.1007/s11030-005-2480-6

D. A. Brown, R. A. Geraty, J. D. Glennon, and N. N. Choileain, -CO-NR'OR, Synthetic Communications, vol.80, issue.13, p.1159, 1985.
DOI : 10.1080/00397918508077259

URL : https://hal.archives-ouvertes.fr/jpa-00210025

K. V. Butler, J. Kalin, C. Brochier, G. Vistoli, B. Langley et al., Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A, Journal of the American Chemical Society, vol.132, issue.31, p.10842, 2010.
DOI : 10.1021/ja102758v

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916045

C. Hubbert, A. Guardiola, R. Shao, Y. Kawaguchi, A. Ito et al., HDAC6 is a microtubule-associated deacetylase, Nature, vol.417, issue.6887, p.455, 2002.
DOI : 10.1038/417455a

N. T}-okési, A. Lehotzky, I. Horváth, B. Szabó, J. Oláh et al., TPPP/p25 Promotes Tubulin Acetylation by Inhibiting Histone Deacetylase 6, Journal of Biological Chemistry, vol.285, issue.23, p.17896, 2010.
DOI : 10.1074/jbc.M109.096578

V. Mangas-sanjuan, J. Oláh, I. Gonzalez-alvarez, A. Lehotzky, N. T}-okési et al., Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors, British Journal of Pharmacology, vol.272, issue.Pt 8, p.829, 2015.
DOI : 10.1111/bph.12946

C. J. Millard, P. J. Watson, I. Celardo, Y. Gordiyenko, S. M. Cowley et al., Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates, Molecular Cell, vol.51, issue.1, p.57, 2013.
DOI : 10.1016/j.molcel.2013.05.020

V. Zwick, A. Chatzivasileiou, N. Deschamps, and M. Roussaki, Aurones as histone deacetylase inhibitors: Identification of key features, Bioorganic & Medicinal Chemistry Letters, vol.24, issue.23, p.5497, 2014.
DOI : 10.1016/j.bmcl.2014.10.019

P. K. Gupta, R. C. Reid, L. Liu, A. J. Lucke, S. A. Broomfield et al., Inhibitors selective for HDAC6 in enzymes and cells, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.23, p.7067, 2010.
DOI : 10.1016/j.bmcl.2010.09.100